Myasthenia Gravis Daily Support Plan: Fatigue-Aware Scheduling and Provider Coordination

Key Points

• MG qualifies for NDIS when treatment has not achieved adequate symptom control and functional impairment substantially limits daily life; the pattern of fatigable weakness means that functional assessment must be conducted at a time of day that reflects the person’s actual functional status
• Fatigue in MG is fatigable muscle weakness: muscles fail with activity and recover with rest; scheduling must distribute demanding tasks with rest periods and concentrate the most demanding activities in the morning
• Myasthenic crisis is a medical emergency requiring immediate emergency services; support workers must know the person’s baseline and recognise significant deterioration in breathing or swallowing
• Medication timing is a clinical priority; pyridostigmine must be given at precisely scheduled times; any missed or delayed doses can cause worsening; new medications must be checked with the neurologist for MG contraindications
• Heat significantly worsens MG symptoms; support workers should help maintain cool environments on hot days
• Myasthenia Alliance Australia provides peer support, information, treatment advocacy, and NDIS navigation for people with MG across Australia

---

Myasthenia Gravis at Home

Myasthenia gravis is an autoimmune condition affecting the neuromuscular junction: antibodies (most commonly against the acetylcholine receptor, AChR) interfere with nerve-to-muscle signal transmission, causing fatigable muscle weakness. The weakness characteristically worsens with repeated muscle use and improves with rest.

In Australia, approximately 5,000 to 7,000 people have myasthenia gravis. The condition affects people of all ages but has two main peaks: young women (20s to 30s) and older men (50s to 70s). With appropriate treatment, most people with MG can achieve good symptom control and maintain their daily activities; however, a significant minority have refractory or severe MG that substantially limits function despite treatment.

The distinctive fatigue pattern of MG creates specific challenges for daily planning that differ from other neuromuscular or fatigue conditions. This guide covers the NDIS pathway, how to build a fatigue-aware daily support plan, the provider team, and what all support workers must know about MG safety.

---

NDIS Access for Myasthenia Gravis

MG is an autoimmune condition rather than a genetic one; NDIS access requires demonstrating functional impairment, not simply confirming diagnosis.

Who is more likely to qualify:

• People with generalised MG (affecting multiple muscle groups) with inadequate treatment response
• People with MG affecting bulbar muscles (speech, swallowing) significantly impacting communication or nutritional intake
• People with MG affecting respiratory muscles with ongoing respiratory symptoms
• People with MG and significant functional limitations in daily self-care, domestic tasks, or community access

Functional evidence required:

• Neurologist or neuromuscular specialist report documenting: diagnosis, treatment history, current treatment, and functional impacts on daily activities
• Ideally includes functional capacity assessment or detailed description of what the person cannot do as a result of MG
• Note: MG symptoms fluctuate; the functional evidence should reflect the person’s typical functional status, not just their best or worst days

What NDIS funds for MG:

• Core: Personal care, daily living support, community access
• Capacity Building: OT, exercise physiology, psychology, support coordination
• Capital: Adaptive equipment, assistive technology prescribed by OT

---

Understanding Fatigable Weakness

The foundational concept for planning support with MG is fatigable weakness. This is not general tiredness or chronic fatigue syndrome; it is a specific pattern where muscles progressively weaken with repeated use and recover with rest.

Common functional impacts by muscle group:

The Daily Energy Pattern

MG symptoms are typically:

• Best: In the morning, after overnight rest and after pyridostigmine takes effect
• Worst: In the afternoon, after cumulative activity has depleted muscle reserve; in hot weather; during or after infection

Support planning must build around this pattern.

---

Building a Fatigue-Aware Daily Schedule

The OT leads the development of a fatigue-aware schedule, working with the person to understand their daily tasks and energy patterns.

Principles of Fatigue-Aware Scheduling

Morning is the highest-functioning period: Schedule demanding activities (showering, meal preparation, community appointments, exercise) in the morning after medication has taken effect. Where possible, appointments should be in the morning.

Rest periods are therapeutic: Rest is not a failure; it is what allows muscles to recover. Scheduled rest periods (30 to 60 minutes lying down, not just sitting) between demanding tasks extend functional capacity across the day.

Distribute, do not concentrate: Spreading demanding tasks throughout the day with rest between them achieves more total function than concentrating activities and then collapsing.

Reduce task effort: Energy conservation strategies (sitting for tasks, lightweight equipment, long-handled tools to avoid overhead reach) reduce the physical demand of each task, preserving energy reserve.

Medication timing anchors the schedule: The schedule should be built around pyridostigmine timing; the peak effect of pyridostigmine typically occurs 30 to 60 minutes after the dose, and this is when demanding activities should be scheduled.

A Sample Fatigue-Aware Daily Plan

This schedule is individualised by the OT based on the person’s specific pattern.

---

The Provider Team

Neurologist or Neuromuscular Specialist

The neurologist manages MG diagnosis, treatment, and monitoring. Key responsibilities:

• Treatment adjustment (medication doses, immunosuppression levels, referral for newer biologics)
• Monitoring for treatment side effects (particularly with long-term corticosteroids)
• Advising on new medications for safety (many common medications worsen MG)
• Managing myasthenic crisis (hospital admission; ICU if respiratory compromise)
• Thymectomy consideration and coordination with thoracic surgery

Occupational Therapist

As described above, the OT’s central role is energy conservation, activity scheduling, home assessment, and adaptive equipment. A good OT for MG:

• Understands the fatigable weakness pattern and schedules the assessment at the person’s functional best
• Assesses the full daily routine, not just individual tasks
• Considers the hot weather factor and heat management strategies
• Involves the person in designing the fatigue-aware schedule; a schedule the person did not design is rarely followed

Exercise Physiologist

An exercise physiologist with neuromuscular experience develops an adapted exercise program. Goals:

• Maintaining cardiovascular fitness and muscle strength within safe limits
• Counteracting the deconditioning that can occur from avoiding activity due to fatigue
• Water-based exercise is often well-suited to MG (buoyancy reduces gravitational load)

The program must be developed with the neurologist’s awareness and should avoid the specific muscle groups most severely affected.

Community Nurse

Community nursing for MG:

• Monitoring for signs of myasthenic crisis or significant worsening
• Medication management, particularly for people on complex immunosuppression
• Liaison with the neurologist for any clinical concerns
• Post-crisis recovery support after hospital discharge

Support Workers

Support workers for MG:

• Understand the fatigable weakness pattern; do not interpret afternoon weakness as laziness or non-compliance
• Follow the fatigue-aware schedule developed by the OT
• Assist with tasks that become too demanding later in the day
• Know the signs of myasthenic crisis and the escalation protocol
• Never allow missed or delayed pyridostigmine doses; this is a clinical priority

---

Crisis Planning

Every person with MG should have a documented crisis plan that includes:

Warning signs of worsening:

• Increased ptosis (worse drooping eyelids than usual baseline)
• Increased double vision
• Worsening speech (more nasal or slurred than usual)
• Increasing difficulty swallowing
• Shortness of breath, especially at rest
• Rapid deterioration from their normal baseline

When to call the neurologist or GP:

• Any of the above that is new or worsening significantly from baseline
• Any infection (may need pyridostigmine dose adjustment)
• Any new medication prescribed by another doctor (need to check for MG contraindications)

When to call 000:

• Significant difficulty breathing
• Inability to swallow or clear secretions
• Rapid deterioration suggesting myasthenic crisis

Hospital information:

• The person should carry a medical alert card or ID indicating they have MG and listing contraindicated medications
• Myasthenia Alliance Australia provides medical alert information resources

---

Key Resources

• Myasthenia Alliance Australia - peer support, information, and treatment advocacy
• Neurological Council of Western Australia - MG information - current information on MG management
• NDIS Assistive Technology information - equipment funding guidance
• My Aged Care - for people 65 and over needing home support (1800 200 422)

---

Connecting with MG Support Providers

Carevo connects people with myasthenia gravis to OTs, exercise physiologists, community nurses, and NDIS-registered daily support providers across Australia.

Find a myasthenia gravis support provider through Carevo